This is a preview of subscription content, log in via an institution to check access.
Reference
Buchanan J, et al. Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis. PharmacoEconomics : 31 Jul 2017. Available from: URL: http://dx.doi.org/10.1007/s40273-017-0519-z
Rights and permissions
About this article
Cite this article
Genomic testing for CLL treatment not cost effective in UK. PharmacoEcon Outcomes News 784, 17 (2017). https://doi.org/10.1007/s40274-017-4228-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4228-9